Table 2 Type and number of malignancies developed in the 40 studied Moroccan Xeroderma pigmentosum patients
P | Age of first Tm (Y) | Skin malignancies | Ocular malignancies | T | ||||
|---|---|---|---|---|---|---|---|---|
BCC | SCC | Melanoma | BCC | SCC | Melanoma | |||
XP1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP2 | 7 | 4 | 2 | 7 | 1 | 0 | 2 | 16 |
XP3 | 14 | 4 | 0 | 1 | 0 | 0 | 1 | 6 |
XP4 | 9 | 25 | 6 | 0 | 1 | 1 | 0 | 33 |
XP5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP6 | 3.5 | 3 | 2 | 1 | 0 | 0 | 0 | 6 |
XP7 | 18 | 5 | 0 | 8 | 0 | 0 | 0 | 13 |
XP8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP9 | 42 | 11 | 2 | 0 | 0 | 0 | 0 | 13 |
XP10 | 4 | 18 | 1 | 1 | 0 | 0 | 0 | 20 |
XP11 | 7 | 11 | 0 | 1 | 0 | 0 | 0 | 12 |
XP12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP13 | 6 | 8 | 0 | 0 | 0 | 0 | 0 | 8 |
XP14 | 13 | 6 | 0 | 0 | 0 | 0 | 0 | 6 |
XP15 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
XP16 | 19 | 2 | 1 | 0 | 0 | 0 | 0 | 3 |
XP17 | 4 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
XP18 | 4 | 8 | 1 | 0 | 0 | 0 | 0 | 9 |
XP19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP20 | 14 | 4 | 0 | 0 | 0 | 0 | 0 | 4 |
XP21 | 5 | 6 | 6 | 0 | 0 | 0 | 0 | 12 |
XP22 | 12 | 44 | 1 | 0 | 2 | 0 | 0 | 47 |
XP23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP24 | 14 | 18 | 0 | 0 | 1 | 0 | 0 | 19 |
XP25 | 10 | 5 | 1 | 0 | 0 | 0 | 0 | 6 |
XP26 | 18 | 5 | 0 | 1 | 0 | 0 | 1 | 7 |
XP27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP28 | 5 | 5 | 3 | 3 | 0 | 0 | 0 | 11 |
XP29 | 21 | 8 | 2 | 0 | 1 | 0 | 0 | 11 |
XP30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP32 | 8 | 27 | 6 | 0 | 3 | 0 | 0 | 36 |
XP33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP34 | 33 | 4 | 3 | 0 | 1 | 0 | 0 | 8 |
XP35 | 17 | 10 | 0 | 0 | 1 | 1 | 0 | 12 |
XP36 | 5 | 3 | 0 | 0 | 0 | 0 | 0 | 3 |
XP37 | 15 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
XP38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XP40 | 28 | 0 | 1 | 0 | 0 | 1 | 0 | 2 |